SIRT1 accelerates the progression of activity-based anorexia

Area of Science:

• Neuroscience
• Metabolic regulation
• Eating disorders

Background:

• Eating disorders, like anorexia nervosa (AN), are severe conditions impacting food consumption and health.
• AN involves persistent energy intake restriction, fear of weight gain, and distorted body perception.

Purpose of the Study:

• To investigate the role of SIRT1 in the development and progression of anorexia nervosa behaviors.
• To explore SIRT1 as a potential therapeutic target for AN.

Main Methods:

• Utilized genetic and pharmacological inhibition of SIRT1 in activity-based anorexia (ABA) models.
• Examined the interaction between SIRT1, NRF1, and the NMDA receptor subunit Grin2A.
• Analyzed the effects of SIRT1 activation and inhibition on ABA phenotypes.

Main Results:

• SIRT1 inhibition delayed the onset and progression of AN behaviors in ABA models.
• SIRT1 activation accelerated ABA phenotypes.
• Mechanistically, SIRT1 interacts with NRF1, suppressing Grin2A, potentially creating a positive feedback loop driving AN behaviors.

Conclusions:

• SIRT1 plays a critical role in promoting anorexia nervosa behaviors.
• Inhibition of SIRT1 may offer a therapeutic strategy to break the cycle of AN.
• Targeting SIRT1 could disrupt pathological feedback loops involving food restriction, anxiety, hyperactivity, and addiction to starvation.